Back

Titin-truncating variants associates with atrial fibrillation, compromises assembly of the sarcomere

25 August 2018 (11:18 - 11:36)
Organised by:
Congress Presentation Part of: New approaches to the treatment of atrial fibrillation Genetics, Epigenetics, ncRNA ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Morten Olesen

University of Copenhagen, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
New approaches to the treatment of atrial fibrillation - State of the art
Professor D. Dobrev (Essen, DE)
Presentation thumbnail
Local optogenetic therapy for acute shock-free termination of atrial fibrillation in vivo
Doctor E. Nyns (Rotterdam, NL)
Abstract
Presentation thumbnail
Inhibition of TASK-1 by gene therapy and pharmacological compounds suppresses atrial fibrillation in a large animal model
Doctor C. Schmidt (Goettingen, DE)
Abstract
Presentation thumbnail
Translational challenges in atrial fibrillation
Professor H. Spronk (Maastrich, NL)
Slides Video

Access the full session

Session thumbnail
New approaches to the treatment of atrial fibrillation

The Event

Event poster

ESC Congress 2018

25 August 2018 11:18 CET
You may be interested in
thumbnail
Congress Presentation
Loss of function in cytoskeletal genes associates with early onset atrial fibrillation
1 September 2019
thumbnail
Congress Presentation
Insights on Titin cardiomyopathy: from truncating variants site to phenotypic expression and outcomes
26 August 2023
thumbnail
Congress Session
How to manage athletes with arrhythmias and potentially arrhythmogenic conditions
30 March 2025
thumbnail
Congress Session
Genetics: primary arrhythmia syndromes and sudden cardiac death
1 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources